drug · antibody drug conjugate
cetuximab sarotalocan
Phase 3updated 3mo agoby Rakuten Medical Inc🔗 ChEMBL
Phase 3community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Approval (across all indications), with an approval for head and neck malignant neoplasia and 1 investigational indication.
targets
Epidermal growth factor receptor
all catalysts(0)
nothing on the calendar yet
Trials studying cetuximab sarotalocan
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that